{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:10:18Z","timestamp":1789665018397,"version":"4.0.1"},"reference-count":292,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neuint.2022.105327","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T03:04:49Z","timestamp":1647831889000},"page":"105327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics"],"prefix":"10.1016","volume":"156","author":[{"given":"Divya","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7444-2344","authenticated-orcid":false,"given":"Pravir","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2022.105327_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","author":"Abrams","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/CIA.S239350","article-title":"Circulating glutamine and alzheimer's disease: a mendelian randomization study","volume":"15","author":"Adams","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.neuint.2022.105327_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2019.06.004","article-title":"Pharmacological antagonism of histamine H2R ameliorated L-DOPA\u2013induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD","volume":"81","author":"Ahmed","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2022.105327_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12031-011-9539-x","article-title":"Changes in the mRNA levels of \u03b12A and \u03b12C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesia","volume":"46","author":"Alachkar","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/exnr.2000.7362","article-title":"An altered histaminergic innervation of the substantia nigra in Parkinson's disease","volume":"163","author":"Anichtchik","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib6","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jcsm.12422","article-title":"Histaminergic transmission slows progression of amyotrophic lateral sclerosis","volume":"10","author":"Apolloni","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.neuint.2022.105327_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153793","article-title":"Histamine is an inducer of the heat shock response in SOD1-G93A models of ALS","volume":"20","author":"Apolloni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00213-019-5182-y","article-title":"Chronic administration of the histamine H3 receptor agonist immepip decreases l-Dopa-induced dyskinesias in 6-hydroxydopamine-lesioned rats","volume":"236","author":"Avila-Luna","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pbb.2011.09.009","article-title":"Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by \u03b1- and \u03b2-adrenergic receptor antagonists in hemiparkinsonian rats","volume":"100","author":"Barnum","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2022.105327_bib10","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/jnr.24710","article-title":"Mechanisms underlying the enhancement of \u03b3-aminobutyric acid responses in the external globus pallidus of R6\/2 Huntington's disease model mice","volume":"98","author":"Barry","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neuint.2022.105327_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.26287","article-title":"Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies","volume":"30","author":"Benarroch","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib13","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuint.2022.105327_bib14","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental parkinsonism by lesions of the subthalamic nucleus","volume":"249","author":"Bergman","year":"1990","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neuint.2022.105327_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11307-020-01561-1","article-title":"Kinetic modelling and test\u2013retest reproducibility for the dopamine D1R radioligand [11C]SCH23390 in healthy and diseased mice","volume":"23","author":"Bertoglio","year":"2021","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.neuint.2022.105327_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000585","article-title":"Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer's model of adult zebrafish brain","volume":"18","author":"Bhattarai","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuint.2022.105327_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib18","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1111\/ejn.14886","article-title":"Dopamine depletion induces neuron-specific alterations of GABAergic transmission in the mouse striatum","volume":"52","author":"Boccalaro","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib19","doi-asserted-by":"crossref","DOI":"10.1046\/j.1469-7580.2000.19640527.x","article-title":"Synaptic organisation of the basal ganglia","author":"Bolam","year":"2000","journal-title":"J. Anat."},{"key":"10.1016\/j.neuint.2022.105327_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184552","article-title":"Enhanced function and overexpression of metabotropic glutamate receptors 1 and 5 in the spinal Cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis during disease progression","volume":"20","author":"Bonifacino","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib21","doi-asserted-by":"crossref","DOI":"10.1586\/14737175.6.1.81","article-title":"Dopamine agonists in the treatment of Parkinson's disease","author":"Bonuccelli","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuint.2022.105327_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2020.103471","article-title":"5-HT2A\/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A)","volume":"279","author":"Borkowski","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib23","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/jnr.24714","article-title":"Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis","volume":"98","author":"Boussicault","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib24","author":"Braak"},{"key":"10.1016\/j.neuint.2022.105327_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2013.06.003","article-title":"Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems","author":"Brichta","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","author":"Brown","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2016.04.044","article-title":"The impact of metabotropic glutamate receptors into active neurodegenerative processes: a \u201cdark side\u201d in the development of new symptomatic treatments for neurologic and psychiatric disorders","author":"Bruno","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","author":"Calabresi","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib29","first-page":"25","article-title":"Effect of MPTP-induced denervation on basal ganglia GABA B receptors: correlation with dopamine concentrations and dopamine transporter","volume":"40","author":"Calon","year":"2001","journal-title":"Synapse (N. Y.)"},{"key":"10.1016\/j.neuint.2022.105327_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1211\/0022357011775587","article-title":"Clonidine-induced antinociception and locomotor hypoactivity are reduced by dexamethasone in mice","volume":"53","author":"Capasso","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(86)91112-1","article-title":"Cellular localization of adrenergic receptors in rat and human brain","author":"Cash","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(84)90117-3","article-title":"Adrenergic receptors in Parkinson's disease","author":"Cash","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib33","article-title":"The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia","volume":"10","author":"Castello","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib34","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-191683","article-title":"Parkinson's disease in women and men: what's the difference?","author":"Cerri","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroscience.2019.04.008","article-title":"Effects of muscarinic acetylcholine m1 and m4 receptor blockade on dyskinesia in the hemi-parkinsonian rat","volume":"409","author":"Chambers","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105327_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1440-1681.1999.03151.x","article-title":"The \u201cABC\u201d of GABA receptors a brief review","volume":"26","author":"Chebib","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuint.2022.105327_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cellsig.2006.05.028","article-title":"Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons","volume":"19","author":"Chen","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuint.2022.105327_bib38","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1523\/JNEUROSCI.2636-19.2020","article-title":"Cerebral dopamine neurotrophic factor regulates multiple neuronal subtypes and behavior","volume":"40","author":"Chen","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.1446-19.2019","article-title":"SIRT3 haploinsufficiency aggravates loss of GABAergic interneurons and neuronal network hyperexcitability in an Alzheimer's disease model","volume":"40","author":"Cheng","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106963","article-title":"Dopamine D1 receptor agonist A-68930 ameliorates A\u03b21-42-induced cognitive impairment and neuroinflammation in mice","volume":"88","author":"Cheng","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuint.2022.105327_bib41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/mdc3.12466","article-title":"The relationship between serotonin-2A receptor and cognitive functions in nondemented Parkinson's disease patients with visual hallucinations","volume":"4","author":"Cho","year":"2017","journal-title":"Movement Disord. Clin. Pract."},{"key":"10.1016\/j.neuint.2022.105327_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104544","article-title":"The physiology and pathophysiology of basal ganglia: from signal transduction to circuits","author":"Chuhma","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002839","article-title":"Cholinergic and perfusion brain networks in Parkinson disease dementia","author":"Colloby","year":"2016","journal-title":"Neurology \u00ae"},{"key":"10.1016\/j.neuint.2022.105327_bib44","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/mds.28564","article-title":"Spatial covariance of cholinergic muscarinic M1\/M4 receptors in Parkinson's disease","volume":"36","author":"Colloby","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib45","first-page":"524","article-title":"Neurotransmitter precursors and brain function","volume":"10","author":"Conlay","year":"1982","journal-title":"Neurosci. Neurosurg."},{"key":"10.1016\/j.neuint.2022.105327_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jnc.15151","article-title":"Ascorbate deficiency decreases dopamine release in gulo\u2013\/\u2013 and APP\/PSEN1 mice","volume":"157","author":"Consoli","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105327_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00194","article-title":"Striatal dopamine D2-muscarinic acetylcholine M1 receptor\u2013receptor interaction in a model of movement disorders","volume":"11","author":"Crans","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2014.10.050","article-title":"Neurotransmitter receptor density changes in Pitx3ak mice - a model relevant to Parkinson's disease","volume":"285","author":"Cremer","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105327_bib49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2022.105327_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2019.02.007","article-title":"Alterations in hippocampal inhibitory synaptic transmission in the R6\/2 mouse model of huntington's disease","volume":"404","author":"Dargaei","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105327_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00221-020-05969-7","article-title":"ALS-CSF-induced structural changes in spinal motor neurons of rat pups cause deficits in motor behaviour","volume":"239","author":"Das","year":"2021","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00067","article-title":"D1 dopamine receptor activation induces neuronal eEF2 pathway-dependent protein synthesis","volume":"13","author":"David","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103500","article-title":"Serotonin in health and disease","author":"de Deurwaerd\u00e8re","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40263-020-00736-2","article-title":"\u03b2-Adrenoceptor drugs and Parkinson's disease: a nationwide nested case\u2013control study","volume":"34","author":"de Germay","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuint.2022.105327_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2015.2397","article-title":"Basal ganglia circuits as targets for neuromodulation in Parkinson disease","author":"DeLong","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108340","article-title":"Serotonin research: crossing scales and boundaries","author":"di Giovanni","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib57","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.933995","article-title":"Video representation of dopamine-responsive multiple system Atrophy cerebellar type","volume":"22","author":"Doan","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib58","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1523\/JNEUROSCI.0902-20.2020","article-title":"Reactive oxygen species modulate activity-dependent AMPA receptor transport in C. elegans","volume":"40","author":"Doser","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib59","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/01616412.2018.1493962","article-title":"Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats","volume":"40","author":"Du","year":"2018","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1135","article-title":"Clinical characteristics and quality of life in Chinese patients with multiple system atrophy","volume":"8","author":"Du","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuint.2022.105327_bib61","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/awz065","article-title":"Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration","volume":"142","author":"Durante","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105327_bib62","article-title":"CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease","author":"Eldrup","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuint.2022.105327_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1474-8673.2006.00368.x","article-title":"Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function","volume":"26","author":"Eglen","year":"2006","journal-title":"Autonom. Autacoid Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s10286-021-00808-3","article-title":"Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension","author":"Eisenhofer","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00981","article-title":"Dopamine receptor D3 expression is altered in CD4+ T-cells from Parkinson's disease patients and its pharmacologic inhibition attenuates the motor impairment in a mouse model","volume":"10","author":"Elgueta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuint.2022.105327_bib66","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/mds.27488","article-title":"Pimavanserin for Parkinson's Disease psychosis: effects stratified by baseline cognition and use of cognitive-enhancing medications","volume":"33","author":"Espay","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbi.2020.11.036","article-title":"Histamine-4 receptor antagonist ameliorates Parkinson-like pathology in the striatum","volume":"92","author":"Fang","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuint.2022.105327_bib68","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s12035-019-01818-z","article-title":"mGluR5 allosteric modulation promotes neurorecovery in a 6-OHDA-toxicant model of Parkinson's disease","volume":"57","author":"Farmer","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.57017","article-title":"M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in huntington's disease","volume":"9","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neuint.2022.105327_bib70","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-020-00794-4","article-title":"Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease","volume":"18","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuint.2022.105327_bib71","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-021-01064-z","article-title":"Drug repurposing: a network-based approach to amyotrophic lateral sclerosis","author":"Fiscon","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuint.2022.105327_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107997","article-title":"The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets","volume":"167","author":"Fisher","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-003-0059-x","article-title":"Dopamine receptor agonists in the therapy of Parkinson's disease","author":"Foley","year":"2004","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105327_bib74","doi-asserted-by":"crossref","DOI":"10.2217\/nmt-2016-0005","article-title":"Nondopaminergic treatments for Parkinson's disease: current and future prospects","author":"Freitas","year":"2016","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.neuint.2022.105327_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107725","article-title":"Activation of mGlu2\/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism","volume":"158","author":"Frouni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2017.03.013","article-title":"18F-fallypride PET-CT of dopamine D2\/D3 receptors in patients with sporadic amyotrophic lateral sclerosis","volume":"377","author":"Fu","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.neuint.2022.105327_bib77","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/1087057116665567","article-title":"Functional characterization of acetylcholine receptors 2016","volume":"21","author":"Fukushima","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.neuint.2022.105327_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.670467","article-title":"Striatal synapse degeneration and dysfunction are reversed by reactivation of Wnt signaling","volume":"13","author":"Galli","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-9-15","article-title":"Genetic variability of histamine receptors in patients with Parkinson's disease","volume":"9","author":"Garc\u00eda-Mart\u00edn","year":"2008","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neuint.2022.105327_bib80","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1007\/s12035-021-02461-3","article-title":"Glutamate delta-1 receptor regulates inhibitory neurotransmission in the nucleus accumbens core and anxiety-like behaviors","volume":"58","author":"Gawande","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(96)00915-8","article-title":"A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome","author":"Gerlach","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-021-00224-0","article-title":"GABAA receptors: structure, function, pharmacology, and related disorders","author":"Ghit","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.neuint.2022.105327_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00702-020-02158-2","article-title":"Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy","volume":"127","author":"Glat","year":"2020","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105327_bib84","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00002826-199310000-00004","article-title":"Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys","volume":"16","author":"Gomez-Mancilla","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78446-4","article-title":"New information of dopaminergic agents based on quantum chemistry calculations","volume":"10","author":"Goode-Romero","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib86","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-010-2153-8","article-title":"Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings","author":"Graef","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2016.06.041","article-title":"The basal ganglia over 500 million years","author":"Grillner","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuint.2022.105327_bib88","series-title":"The Basal Ganglia and Motor Control, NEURAL PLASTICITY","author":"Groenewegen","year":"2003"},{"key":"10.1016\/j.neuint.2022.105327_bib89","first-page":"585","article-title":"Activation and blockade of serotonin4 receptors in the lateral habenula improve working memory in unilateral 6-hydroxydopamine-lesioned Parkinson's rats","volume":"41","author":"Guo","year":"2019","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib90","author":"Hallett"},{"key":"10.1016\/j.neuint.2022.105327_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2019-322038","article-title":"Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington's disease (Enroll-HD)","author":"Harris","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuint.2022.105327_bib92","article-title":"Reduced expression of dopamine D2 receptors on astrocytes in R6\/1 HD mice and HD post-mortem tissue","author":"Harris","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105327_bib93","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/2211-5463.13285","article-title":"Multiplatform metabolomic analysis of the R6\/2 mouse model of Huntington's disease","volume":"11","author":"Hashimoto","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.neuint.2022.105327_bib94","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3233\/JHD-180318","article-title":"Increased serotonin transporter expression in huntington's disease patients is not consistently replicated in murine models","volume":"8","author":"He","year":"2019","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib95","doi-asserted-by":"crossref","DOI":"10.3109\/07853899608999120","article-title":"Special section: schizophrenia dopamine in schizophrenia","author":"Hietala\u2019","year":"1996","journal-title":"Ann. Med."},{"key":"10.1016\/j.neuint.2022.105327_bib96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2012.03.034","article-title":"The role of the GABA B receptor and calcium channels in a Drosophila model of Parkinson's Disease","volume":"516","author":"Hillman","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105327_bib97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ejn.14283","article-title":"Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease","volume":"49","author":"Holley","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237472","article-title":"Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease","volume":"15","author":"Hong","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105327_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109224","article-title":"Human amyotrophic lateral sclerosis excitability phenotype screen: target discovery and validation","volume":"35","author":"Huang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib100","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-019-0071-6","article-title":"Improved synthesis of [18F] fallypride and characterization of a Huntington's disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2\/D3 receptors","volume":"4","author":"Huhtala","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.neuint.2022.105327_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104844","article-title":"Dopamine D4 receptors in the lateral habenula regulate depression-related behaviors via a pre-synaptic mechanism in experimental Parkinson's disease","volume":"140","author":"Hui","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib102","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2217\/nmt.11.62","article-title":"Nondopaminergic treatments for Parkinson's disease","volume":"1","author":"Huot","year":"2011","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.neuint.2022.105327_bib103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cub.2005.02.037","article-title":"Neurotransmitters","author":"Hyman","year":"2005","journal-title":"Current biology"},{"key":"10.1016\/j.neuint.2022.105327_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.665820","article-title":"Cholinergic receptor modulation as a target for preventing dementia in Parkinson's disease","author":"Iarkov","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2015.01.012","article-title":"Activity of serotonin 5-HT1A receptor \u201cbiased agonists\u201d in rat models of Parkinson's disease and l-DOPA-induced dyskinesia","volume":"93","author":"Iderberg","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib106","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3233\/JPD-202047","article-title":"Blinded SAPS-PD assessment after 10 Weeks of pimavanserin treatment for Parkinson's disease psychosis","volume":"10","author":"Isaacson","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2169\/internalmedicine.4836-20","article-title":"Effectiveness of levodopa in patients with multiple system atrophy and associated clinicopathological features","volume":"60","author":"Ishida","year":"2021","journal-title":"Intern. Med."},{"key":"10.1016\/j.neuint.2022.105327_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215340","article-title":"Serotonin 5-HT4 receptor agonists improve facilitation of contextual fear extinction in an MPTP-induced mouse model of Parkinson's disease","volume":"20","author":"Ishii","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib109","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","article-title":"Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson's disease and huntington's disease: a review","volume":"17","author":"Jamwal","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuint.2022.105327_bib111","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1172\/JCI127695","article-title":"Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment","volume":"129","author":"Jiang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2022.105327_bib112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1568007033482805","article-title":"GABA(C) receptors as drug targets","volume":"2","author":"Johnston","year":"2003","journal-title":"Curr. Drug Targets - CNS Neurol. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib113","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.27565","article-title":"Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques","volume":"34","author":"Johnston","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib114","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.23069","article-title":"Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease","volume":"25","author":"Johnston","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(93)90414-I","article-title":"Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases","author":"Joyce","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib116","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuint.2007.06.035","article-title":"Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via \u03b11- and \u03b21\/\u03b22-adrenergic receptors","volume":"52","author":"Juri\u010d","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib117","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2967\/jnumed.119.227140","article-title":"Presynaptic striatal dopaminergic function in atypical parkinsonism: a metaanalysis of imaging studies","volume":"60","author":"Kaasinen","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuint.2022.105327_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2022.105327_bib119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jon.12563","article-title":"18F-FPEB PET\/CT shows mGluR5 upregulation in Parkinson's disease","volume":"29","author":"Kang","year":"2019","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.neuint.2022.105327_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127838","article-title":"Discovery and optimization of a novel CNS penetrant series of mGlu4 PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model","volume":"37","author":"Kent","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2022.105327_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77652-4","article-title":"Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection","volume":"10","author":"Kikuoka","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib122","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jphs.2017.04.002","article-title":"Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease","volume":"134","author":"Kinoshita","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib123","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1021\/acschemneuro.8b00274","article-title":"Increased cholinergic response in \u03b1-synuclein transgenic mice (h-\u03b1-synL62)","volume":"10","author":"K\u00f6nig","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134932","article-title":"Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease","volume":"729","author":"Koski","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105327_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01005","article-title":"Characterization of PF-6142, a novel, non-catecholamine dopamine receptor D1 agonist, in murine and nonhuman primate models of dopaminergic activation","volume":"11","author":"Kozak","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib126","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1007\/s00415-021-10514-9","article-title":"Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson's disease","volume":"268","author":"Kr\u00e4mer","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2008.11.005","article-title":"Striatal plasticity and basal ganglia circuit function","author":"Kreitzer","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105327_bib128","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/mds.28608","article-title":"Longitudinal analysis of multiple neurotransmitter metabolites in cerebrospinal fluid in early Parkinson's disease","volume":"36","author":"Kremer","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-019-05354-5","article-title":"Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071","volume":"237","author":"Kucinski","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib130","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00213-021-05822-x","article-title":"Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071","volume":"238","author":"Kucinski","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gaitpost.2020.08.132","article-title":"Dopamine-mediated improvements in dynamic balance control in Parkinson's disease","volume":"82","author":"Kuhman","year":"2020","journal-title":"Gait Posture"},{"key":"10.1016\/j.neuint.2022.105327_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172914","article-title":"Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease","volume":"871","author":"Kwan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib133","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009621","article-title":"Functional neuroanatomy of the basal ganglia","volume":"2","author":"Lanciego","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.neuint.2022.105327_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2015.02.006","article-title":"\u03b12-Adrenoceptors in the treatment of major neuropsychiatric disorders","author":"Langer","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113534","article-title":"Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia","volume":"336","author":"Lanza","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib136","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3233\/JPD-160932","article-title":"Muscarinic M1 receptor coupling to G-protein is intact in Parkinson's disease dementia","volume":"6","author":"Lee","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib137","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuron.2012.09.012","article-title":"Neuromodulation of brain states","author":"Lee","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105327_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105220","article-title":"Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans","volume":"163","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147072","article-title":"Activation and blockade of 5-HT6 receptor in the medial septum-diagonal band recover working memory in the hemiparkinsonian rats","volume":"1748","author":"Li","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/jpet.121.000735","article-title":"Metabotropic glutamate receptor 2\/3 activation improves motor performance and reduces pathology in heterozygous zQ175 huntington disease mice","volume":"379","author":"Li","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2022.105327_bib141","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3171\/jns.1999.90.5.0928","article-title":"Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidus","volume":"90","author":"Lieberman","year":"1999","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuint.2022.105327_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2020.626412","article-title":"Enhanced GABAergic inhibition of cholinergic interneurons in the zQ175+\/\u2212 mouse model of huntington's disease","volume":"14","author":"Lim","year":"2021","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104696","article-title":"Cerebral dopamine neurotrophic factor\u2013deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice","volume":"134","author":"Lindahl","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib144","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0438-19.2020","article-title":"Chronic activation of gp1 mglurs leads to distinct refinement of neural network activity through non-canonical p53 and akt signaling","volume":"7","author":"Liu","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.neuint.2022.105327_bib145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01616412.2019.1611204","article-title":"Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson's disease","volume":"41","author":"Liu","year":"2019","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112207","article-title":"Serotonin1A receptors in the dorsal hippocampus regulate working memory and long-term habituation in the hemiparkinsonian rats","volume":"376","author":"Liu","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib147","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.18632\/aging.102095","article-title":"Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.neuint.2022.105327_bib148","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1523\/JNEUROSCI.2028-18.2018","article-title":"Inhibition of nigrostriatal dopamine release by striatal GABA A and GABA B receptors","volume":"39","author":"Lopes","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib149","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13286","article-title":"Antiallergic drug desloratadine as a selective antagonist of 5HT2A receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction","volume":"20","author":"Lu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuint.2022.105327_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108369","article-title":"Blockade of GABA transporter-1 and GABA transporter-3 in the lateral habenula improves depressive-like behaviors in a rat model of Parkinson's disease","volume":"181","author":"Lyu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib151","doi-asserted-by":"crossref","DOI":"10.1017\/S095925981200007X","article-title":"Parkinson's disease - pathology, aetiology and diagnosis","author":"Macphee","year":"2012","journal-title":"Rev. Clin. Gerontol."},{"key":"10.1016\/j.neuint.2022.105327_bib152","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27611","article-title":"Adrenoceptor agonists and antagonists and risk of Parkinson's disease","author":"Maghzi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102268","article-title":"NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model","volume":"91","author":"Magi","year":"2020","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuint.2022.105327_bib154","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-018-09831-0","article-title":"Beta2-Adrenoceptor agonists in Parkinson's disease and other synucleinopathies","author":"Magistrelli","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib155","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson's disease","author":"Mahlknecht","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib156","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/bph.13076","article-title":"The effects of sigma (\u03c31) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice","volume":"172","author":"Malik","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.560","article-title":"T-495, a novel low cooperative M1 receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk","volume":"8","author":"Mandai","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neuint.2022.105327_bib158","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JPD-191824","article-title":"Antiparkinsonian effects of a metabotropic glutamate receptor 4 agonist in MPTP-treated marmosets","volume":"10","author":"Mann","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib159","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-2012-120103","article-title":"Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life","author":"Manson","year":"2012","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6182","article-title":"Parkin regulates kainate receptors by interacting with the GluK2 subunit","volume":"5","author":"Maraschi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2022.105327_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104506","article-title":"Differential enhancement of ERK, PKA and Ca2+ signaling in direct and indirect striatal neurons of Parkinsonian mice","volume":"130","author":"Mariani","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib162","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1007\/s12035-019-1634-y","article-title":"EGF treatment improves motor behavior and cortical GABAergic function in the R6\/2 mouse model of huntington's disease","volume":"56","author":"Marottoli","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031107","article-title":"Implication of 5-HT in the dysregulation of chloride homeostasis in prenatal spinal motoneurons from the G93A mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Martin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib164","article-title":"Mast cells and histamine are involved in the neuronal damage observed in a quinolinic acid-induced model of Huntington's disease","author":"Mart\u00ednez-Gopar","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105327_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.58","article-title":"The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism","volume":"7","author":"Masini","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuint.2022.105327_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.03.004","article-title":"Circuit mechanisms of Parkinson's disease","author":"McGregor","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105327_bib167","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2019.06.013","article-title":"Dopamine deficiency reduces striatal cholinergic interneuron function in models of Parkinson's disease","volume":"103","author":"McKinley","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105327_bib168","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00702-016-1629-z","article-title":"Muscarinic receptor binding changes in postmortem Parkinson's disease","volume":"124","author":"McOmish","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105327_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00077","article-title":"Alterations in GABAA-receptor trafficking and synaptic dysfunction in brain disorders","volume":"13","author":"Mele","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mdc3.12061","article-title":"Famotidine, a histamine H2 receptor antagonist, does not reduce levodopa-induced dyskinesia in Parkinson's disease: a proof-of-concept study","volume":"1","author":"Mestre","year":"2014","journal-title":"Movement Disord. Clin. Pract."},{"key":"10.1016\/j.neuint.2022.105327_bib171","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.28295","article-title":"Brain 5-HT1A receptor binding in multiple system Atrophy: an [18F]-MPPF PET study","volume":"36","author":"Meyer","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib172","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson's disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neuint.2022.105327_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112304","article-title":"Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease","volume":"378","author":"Mishra","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib174","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuint.2018.11.020","article-title":"Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt\/\u03b2-catenin pathways in rat model of Parkinson's disease","volume":"122","author":"Mishra","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib175","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2022.105327_bib176","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"\u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson's disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neuint.2022.105327_bib177","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/acsptsci.0c00162","article-title":"Discovery of the first selective M4Muscarinic acetylcholine receptor antagonists with in vivo antiparkinsonian and antidystonic efficacy","volume":"4","author":"Moehle","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib178","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1515\/revneuro-2016-0068","article-title":"Neurotransmission systems in Parkinson's disease","volume":"28","author":"Moghaddam","year":"2017","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.51093","article-title":"Modulation of dopamine d1 receptors via histamine h3 receptors is a novel therapeutic target for huntington's disease","volume":"9","author":"Moreno-Delgado","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neuint.2022.105327_bib180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00259-018-4179-9","article-title":"Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients","volume":"46","author":"M\u00fcller Herde","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.neuint.2022.105327_bib181","article-title":"Dopamine D3 receptor heteromerization: implications for neuroplasticity and neuroprotection","author":"Mutti","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuint.2022.105327_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2011.10.012","article-title":"GABA-B receptor: possible target for Parkinson's disease therapy","author":"Nambu","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21197329","article-title":"Neuroprotective effect of curcumin on the nigrostriatal pathway in a 6-hydroxydopmine-induced rat model of Parkinson's disease is mediated by \u03b17-nicotinic receptors","volume":"21","author":"Nebrisi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib184","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1124\/jpet.117.245068","article-title":"Curcumin acts as a positive allosteric modulator of a 7 -nicotinic acetylcholine receptors and_ reverses nociception in mouse models of inflammatory pain","volume":"365","author":"Nebrisi","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2022.105327_bib185","first-page":"2655","article-title":"Functional segregation of basal ganglia pathways in Parkinson's disease","volume":"141","author":"Neumann","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105327_bib186","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/RRS-200029981","article-title":"Dopamine receptor signaling","volume":"24","author":"Neve","year":"2004","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104979","article-title":"GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming","volume":"143","author":"Nishijima","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib189","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4419-8056-4_10","article-title":"Histamine in neurotransmission and brain diseases","volume":"709","author":"Nuutinen","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuint.2022.105327_bib190","article-title":"The basal ganglia in Parkinson's disease: current concepts and unexplained observations","author":"Obeso","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease","volume":"23","author":"Obeso","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00806","article-title":"Beyond dopamine: GABA, glutamate, and the axial symptoms of Parkinson disease","volume":"9","author":"O'Gorman Tuura","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181633","article-title":"Dopamine acting at D1-like, D2-like and \u03b11-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex","volume":"12","author":"\u00d6zkan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105327_bib194","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12035-019-01739-x","article-title":"Selective regulation of 5-HT1B serotonin receptor expression in the striatum by dopamine depletion and repeated L-DOPA treatment: relationship to L-DOPA-induced dyskinesias","volume":"57","author":"Padovan-Neto","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105327_bib195","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/bs.irn.2018.08.002","article-title":"Molecular imaging of the serotonergic system in Parkinson's disease","author":"Pagano","year":"2018"},{"key":"10.1016\/j.neuint.2022.105327_bib196","article-title":"Dopamine and dopamine receptors in Alzheimer's disease: a systematic review and network meta-analysis","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib197","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202012095","article-title":"The cell biology of Parkinson's disease","author":"Panicker","year":"2021","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.neuint.2022.105327_bib198","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1017\/cjn.2019.322","article-title":"Preserved serotonergic activity in early-onset Parkinson's disease","volume":"47","author":"Park","year":"2020","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib199","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706440","article-title":"Histamine and its receptors","author":"Parsons","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib200","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4301","article-title":"Complementarity of gluCEST and 1H-MRS for the study of mouse models of Huntington's disease","volume":"33","author":"P\u00e9pin","year":"2020","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuint.2022.105327_bib201","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.27622","article-title":"Enhanced striatopallidal gamma-aminobutyric acid (GABA)A receptor transmission in mouse models of huntington's disease","volume":"34","author":"Perez-Rosello","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib202","series-title":"Progress in Brain Research","first-page":"525","article-title":"Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease","author":"Petersson","year":"2020"},{"key":"10.1016\/j.neuint.2022.105327_bib203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbr.2014.04.028","article-title":"Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model","volume":"269","author":"Philippens","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2014.07.037","article-title":"Serotonin in Parkinson's disease","author":"Politis","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.004","article-title":"Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia","author":"Pourmirbabaei","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105185","article-title":"Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons","volume":"160","author":"Price","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib207","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2021.673177","article-title":"BACHD mice recapitulate the striatal parvalbuminergic interneuron loss found in huntington's disease","volume":"15","author":"Rallapalle","year":"2021","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuint.2022.105327_bib208","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/mds.28569","article-title":"Fluoxetine for the symptomatic treatment of multiple system Atrophy: the MSA-FLUO trial","volume":"36","author":"Rascol","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib209","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3682936","article-title":"5-HT2A receptor binding in the frontal cortex of Parkinson's disease patients and alpha-synuclein overexpressing mice: a postmortem study","author":"Rasmussen","year":"2016","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib210","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03172-8","article-title":"Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity","volume":"11","author":"Regoni","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib211","series-title":"Parkinson's Disease","author":"Reich","year":"2019"},{"key":"10.1016\/j.neuint.2022.105327_bib212","doi-asserted-by":"crossref","DOI":"10.1007\/s12264-017-0159-5","article-title":"Premotor diagnosis of Parkinson's disease","author":"Reichmann","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuint.2022.105327_bib213","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3892\/mmr.2020.11253","article-title":"Expression levels of the \u03b17 nicotinic acetylcholine receptor in the brains of patients with alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells","volume":"22","author":"Ren","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2016.11.013","article-title":"Metabotropic glutamate receptors and neurodegenerative diseases","author":"Ribeiro","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1474-4422(03)00480-0","article-title":"Endogenous dopamine release in Parkinson's disease","volume":"2","author":"Rinne","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib216","series-title":"Movement Disorders","first-page":"59","article-title":"Brain neurotransmitter receptors in Parkinson's disease","author":"Rinne","year":"1981"},{"key":"10.1016\/j.neuint.2022.105327_bib217","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0600-0","article-title":"Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation","volume":"13","author":"Rocha","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2022.105327_bib218","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98241-z","article-title":"TDP-43 regulates GAD1 mRNA splicing and GABA signaling in Drosophila CNS","volume":"11","author":"Romano","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib219","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11064-012-0931-x","article-title":"Cholinergic receptor alterations in the brain stem of spinal cord injured Rats","volume":"38","author":"Romeo","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib220","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/brain\/awaa034","article-title":"Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis","volume":"143","author":"Sahara Khademullah","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105327_bib221","doi-asserted-by":"crossref","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","author":"Sara","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib222","doi-asserted-by":"crossref","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib223","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bph.14076","article-title":"5-HT1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease","volume":"175","author":"Scholpa","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib224","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105327_bib225","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI126361","article-title":"D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease","volume":"130","author":"Sebastianutto","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2022.105327_bib226","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25633-0","article-title":"Structural determinants and regulation of spontaneous activity in GABAA receptors","volume":"12","author":"Sexton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2022.105327_bib227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105327_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2014.12.008","article-title":"The human histaminergic system in neuropsychiatric disorders","author":"Shan","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib229","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2021_237","article-title":"Histamine-4 receptor: emerging target for the treatment of neurological diseases","author":"Shan","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pbr.2021.06.003","article-title":"Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy","volume":"266","author":"Sharma","year":"2021","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib231","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2015.10.039","article-title":"M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia","volume":"88","author":"Shen","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105327_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172957","article-title":"Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset","volume":"873","author":"Sid-Otmane","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib233","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jnc.15129","article-title":"Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer's diseases","volume":"156","author":"Sim\u00f5es-Pires","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105327_bib234","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.13853","article-title":"Oscillatory activity in the cortico-basal ganglia-thalamic neural circuits in Parkinson's disease","author":"Singh","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib235","series-title":"ASTROCYTIC NEUROTRANSMITTER RECEPTORS","author":"Situ","year":"1997"},{"key":"10.1016\/j.neuint.2022.105327_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108136","article-title":"NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism","volume":"174","author":"Sitzia","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib237","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-190577","article-title":"Neurotransmitter imbalance in the brain and alzheimer's disease pathology","volume":"72","author":"Snowden","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113062","article-title":"The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain","volume":"323","author":"Stayte","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib239","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuint.2017.01.007","article-title":"Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment","volume":"105","author":"Stefani","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib240","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75439-1","article-title":"Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington's disease","volume":"10","author":"Stepanova","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00183","article-title":"LY354740 reduces extracellular glutamate concentration, inhibits phosphorylation of Fyn\/NMDARs, and expression of PLK2\/pS129 \u03b1-synuclein in mice treated with acute or sub-acute MPTP","volume":"11","author":"Tan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib242","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuron.2018.12.004","article-title":"Cholinergic interneurons amplify thalamostriatal excitation of striatal indirect pathway neurons in Parkinson's disease models","volume":"101","author":"Tanimura","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105327_bib243","doi-asserted-by":"crossref","DOI":"10.1007\/s10286-020-00679-0","article-title":"Mechanisms underlying unawareness of neurogenic orthostatic hypotension","author":"Tipton","year":"2020","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib244","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson's: a syndrome rather than a disease?","author":"Titova","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105327_bib245","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acschemneuro.0c00154","article-title":"Circular dichroism spectroscopy identifies the \u03b2-adrenoceptor agonist salbutamol as a direct inhibitor of tau filament formation in vitro","volume":"11","author":"Townsend","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib246","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","article-title":"A-Synuclein oligomers induce glutamate release from astrocytes and excessive extrasynaptic nmdar activity in neurons, thus contributing to synapse loss","volume":"41","author":"Trudler","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib247","doi-asserted-by":"crossref","DOI":"10.2174\/156720507781788873","article-title":"TNF-inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets","author":"Tweedie","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2022.105327_bib248","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.etp.2014.12.001","article-title":"Possible role of GABA-B receptor modulation in MPTP induced Parkinson's disease in rats","volume":"67","author":"Tyagi","year":"2015","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.neuint.2022.105327_bib249","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000509278","article-title":"Apathy in alzheimer's disease correlates with the dopamine transporter level in the caudate nuclei","volume":"10","author":"Udo","year":"2020","journal-title":"Dementia Geriatr. Cogn. Disord. Extra"},{"key":"10.1016\/j.neuint.2022.105327_bib250","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson's disease","volume":"41","author":"van Nuland","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuint.2022.105327_bib251","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13037","article-title":"Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation","volume":"18","author":"Velazquez","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuint.2022.105327_bib252","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62864-5","article-title":"Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism","volume":"10","author":"Velebit","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105327_bib253","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11307-019-01400-y","article-title":"Longitudinal PET imaging of \u03b17 nicotinic acetylcholine receptors with [18F]ASEM in a rat model of Parkinson's disease","volume":"22","author":"Vetel","year":"2020","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.neuint.2022.105327_bib254","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27586","article-title":"From beta-blockers to Parkinson's disease in respect of essential tremor","author":"Vogelnik","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2022.105327_bib255","article-title":"Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis","volume":"347","author":"Wang","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib256","article-title":"7-pyrrolidinethoxy-4\u2032-methoxyisoflavone prevents amyloid \u03b2-induced injury by regulating histamine H3 receptor-mediated cAMP\/CREB and AKT\/GSK3\u03b2 pathways","volume":"13","author":"Wang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib257","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1533317516685425","article-title":"In vivo effect of a 5-HT7 receptor agonist on 5-HT neurons and GABA interneurons in the dorsal raphe nuclei of sham and PD rats","volume":"32","author":"Wang","year":"2017","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"key":"10.1016\/j.neuint.2022.105327_bib258","doi-asserted-by":"crossref","DOI":"10.1080\/13543784.2017.1323870","article-title":"Investigational dopamine antagonists for the treatment of schizophrenia","author":"Wang","year":"2017","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2022.105327_bib259","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2017.01.015","article-title":"Involvement of lateral habenula \u03b11 subunit-containing GABAA receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson's disease","volume":"116","author":"Wang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147266","article-title":"Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"1754","author":"Wang","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2022.105327_bib261","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1212\/WNL.49.1_Suppl_1.S34","article-title":"The role of dopamine agonists in early Parkinson's disease","volume":"49","author":"Watts","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105327_bib262","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1523\/JNEUROSCI.3611-14.2015","article-title":"Role of the indirect pathway of the basal ganglia in perceptual decision making","volume":"35","author":"Wei","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib263","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/stem.3232","article-title":"Norepinephrine is a negative regulator of the adult periventricular neural stem cell niche","volume":"38","author":"Weselek","year":"2020","journal-title":"Stem Cell."},{"key":"10.1016\/j.neuint.2022.105327_bib264","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-020-00741-z","article-title":"Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease","volume":"13","author":"Whiley","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2022.105327_bib265","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.605887","article-title":"Monoamine levels and Parkinson's disease progression: evidence from a high-performance liquid chromatography study","volume":"15","author":"Wichit","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib266","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/exnr.2000.7572","article-title":"Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates","volume":"167","author":"Wichmann","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib267","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-190773","article-title":"Reduced hippocampal glutamate and posterior cingulate N-acetyl aspartate in mild cognitive impairment and alzheimer's disease is associated with episodic memory performance and white matter integrity in the cingulum: a pilot study","volume":"73","author":"Wong","year":"2020","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib268","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2012.07.012","article-title":"Basal ganglia circuits changes in Parkinson's disease patients","volume":"524","author":"Wu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105327_bib269","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2019.09.038","article-title":"Activation and blockade of \u03b12-adrenoceptors in the prelimbic cortex regulate anxiety-like behaviors in hemiparkinsonian rats","volume":"519","author":"Wu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2022.105327_bib270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresbull.2017.07.011","article-title":"Prelimbic \u03b11-adrenoceptors are involved in the regulation of depressive-like behaviors in the hemiparkinsonian rats","volume":"134","author":"Wu","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2022.105327_bib271","series-title":"2021 5th International Conference on Information Systems and Computer Networks (ISCON)","first-page":"1","article-title":"Parkinson's Disease: an Overview and Role of Glutamate and its Receptors: glutamate receptor based therapy as an alternate way to treat Parkinson's","author":"Yadav","year":"2021"},{"key":"10.1016\/j.neuint.2022.105327_bib272","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00441-021-03515-7","article-title":"Reduced acetylcholine and elevated muscarinic receptor 2 in duodenal mucosa contribute to the impairment of mucus secretion in 6-hydroxydopamine-induced Parkinson's disease rats","volume":"386","author":"Yan","year":"2021","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuint.2022.105327_bib273","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/acn3.51274","article-title":"Dopamine D1 + D3 receptor density may correlate with Parkinson disease clinical features","volume":"8","author":"Yang","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuint.2022.105327_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100994","article-title":"Dopamine D3 receptor: a neglected participant in Parkinson Disease pathogenesis and treatment?","author":"Yang","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuint.2022.105327_bib275","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s11064-020-03114-y","article-title":"Kukoamine A protects against NMDA-induced neurotoxicity accompanied with down-regulation of GluN2B-containing NMDA receptors and phosphorylation of PI3K\/Akt\/GSK-3\u03b2 signaling pathway in cultured primary cortical neurons","volume":"45","author":"Yang","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2022.105327_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108705","article-title":"Blockade of pre-synaptic and post-synaptic GABAB receptors in the lateral habenula produces different effects on anxiety-like behaviors in 6-hydroxydopamine hemiparkinsonian rats","volume":"196","author":"Yang","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib277","doi-asserted-by":"crossref","DOI":"10.1177\/1073858416654115","article-title":"The basal ganglia in action","author":"Yin","year":"2017","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuint.2022.105327_bib278","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/cells8060595","article-title":"Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6\/2 mouse model of huntington disease","volume":"8","author":"Yu-Taeger","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2022.105327_bib279","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119300","article-title":"Early differences in membrane properties at the neuromuscular junctions of ALS model mice: effects of 25-hydroxycholesterol","volume":"273","author":"Zakyrjanova","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2022.105327_bib280","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-019-01997-y","article-title":"Dopaminergic modulation of striatal function and Parkinson's disease","author":"Zhai","year":"2019","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2022.105327_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107687","article-title":"Blockade of calcium-permeable AMPA receptors in the lateral habenula produces increased antidepressant-like effects in unilateral 6-hydroxydopamine-lesioned rats compared to sham-lesioned rats","volume":"157","author":"Zhang","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105327_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103572","article-title":"Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease","volume":"110","author":"Zhang","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib283","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11481-019-09887-6","article-title":"Histamine induces microglia activation and the release of proinflammatory mediators in rat brain via H1R or H4R","volume":"15","author":"Zhang","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuint.2022.105327_bib284","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02079-1","article-title":"Metabotropic glutamate receptor 5 inhibits \u03b1-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2022.105327_bib285","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104807","article-title":"Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: an electrophysiological perspective","volume":"139","author":"Zheng","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2022.105327_bib286","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2018.11.006","article-title":"Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model","volume":"76","author":"Zhou","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuint.2022.105327_bib287","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of \u03b2-arrestin2 and NLRP3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuint.2022.105327_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104549","article-title":"Norepinephrine upregulates the expression of tyrosine hydroxylase and protects dopaminegic neurons against 6-hydrodopamine toxicity","volume":"131","author":"Zhu","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib289","article-title":"Serotonin 2A receptor autoantibodies increase in adult traumatic brain injury in association with neurodegeneration","author":"Zimering","year":"2020","journal-title":"J. Endocrinol. Diabetes"},{"key":"10.1016\/j.neuint.2022.105327_bib290","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.02.019","article-title":"Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease","author":"Ztaou","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2022.105327_bib291","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1111\/ejn.14153","article-title":"Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice","volume":"48","author":"Ztaou","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105327_bib292","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1523\/JNEUROSCI.0873-16.2016","article-title":"Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease","volume":"36","author":"Ztaou","year":"2016","journal-title":"J. Neurosci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:58:21Z","timestamp":1759312701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018622000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":292,"alternative-id":["S0197018622000523"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105327","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105327"}}